RecruitingNCT04310241

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Oculomotor Disorders: Experimental and Clinical Study


Sponsor

The Cleveland Clinic

Enrollment

150 participants

Start Date

Feb 21, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.


Eligibility

Min Age: 6 MonthsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Patching therapy, Glasses for people with amblyopia and strabismus. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Months to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPatching therapy, Glasses

Patching, glasses and strabismus surgery are commonly employed measures in treatment of amblyopia and strabismus.


Locations(1)

Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04310241


Related Trials